SignatureFD’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-422
| Closed | -$1.48K | – | 3319 |
|
2024
Q3 | $1.48K | Sell |
422
-53
| -11% | -$186 | ﹤0.01% | 2901 |
|
2024
Q2 | $1.56K | Sell |
475
-388
| -45% | -$1.27K | ﹤0.01% | 2812 |
|
2024
Q1 | $6.33K | Buy |
863
+503
| +140% | +$3.69K | ﹤0.01% | 2468 |
|
2023
Q4 | $1.35K | Sell |
360
-624
| -63% | -$2.34K | ﹤0.01% | 2849 |
|
2023
Q3 | $2.09K | Sell |
984
-3,070
| -76% | -$6.52K | ﹤0.01% | 2754 |
|
2023
Q2 | $19.3K | Buy |
4,054
+855
| +27% | +$4.07K | ﹤0.01% | 1910 |
|
2023
Q1 | $18.2K | Buy |
3,199
+918
| +40% | +$5.23K | ﹤0.01% | 1919 |
|
2022
Q4 | $23K | Buy |
2,281
+1,130
| +98% | +$11.4K | ﹤0.01% | 1733 |
|
2022
Q3 | $26K | Buy |
1,151
+81
| +8% | +$1.83K | ﹤0.01% | 1608 |
|
2022
Q2 | $27K | Buy |
1,070
+199
| +23% | +$5.02K | ﹤0.01% | 1618 |
|
2022
Q1 | $34K | Buy |
871
+283
| +48% | +$11K | ﹤0.01% | 1553 |
|
2021
Q4 | $34K | Sell |
588
-313
| -35% | -$18.1K | ﹤0.01% | 1522 |
|
2021
Q3 | $53K | Sell |
901
-6
| -0.7% | -$353 | ﹤0.01% | 1269 |
|
2021
Q2 | $79K | Buy |
907
+715
| +372% | +$62.3K | ﹤0.01% | 1060 |
|
2021
Q1 | $16K | Hold |
192
| – | – | ﹤0.01% | 1644 |
|
2020
Q4 | $17K | Sell |
192
-11
| -5% | -$974 | ﹤0.01% | 1508 |
|
2020
Q3 | $8K | Buy |
203
+48
| +31% | +$1.89K | ﹤0.01% | 1707 |
|
2020
Q2 | $5K | Hold |
155
| – | – | ﹤0.01% | 1788 |
|
2020
Q1 | $3K | Buy |
+155
| New | +$3K | ﹤0.01% | 1809 |
|